Glaucoma Patient Treatment Preferences Presented at: The annual meeting of the Association for Research and Vision in Ophthalmology (ARVO). Denver, CO, May 2015.

Jeffrey R. Soohoo; Liliya Golas; Catherine M. Marando; Leonard K. Seibold; Mina B. Pantcheva; Pradeep Y. Ramulu; Malik Y. Kahook

doi:10.1016/j.ophtha.2016.01.018

Glaucoma Patient Treatment Preferences Presented at: The annual meeting of the Association for Research and Vision in Ophthalmology (ARVO). Denver, CO, May 2015.

Jeffrey R. Soohoo, Liliya Golas, Catherine M. Marando, Leonard K. Seibold, Mina B. Pantcheva, Pradeep Y. Ramulu, Malik Y. Kahook

School of Medicine

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Original language	English (US)
Pages (from-to)	1621-1622
Number of pages	2
Journal	Ophthalmology
Volume	123
Issue number	7
DOIs	https://doi.org/10.1016/j.ophtha.2016.01.018
State	Published - Jul 1 2016

ASJC Scopus subject areas

Ophthalmology

Access to Document

10.1016/j.ophtha.2016.01.018

Cite this

@article{f4c5ee1c1c34439c914e6a5d6f61a442,

title = "Glaucoma Patient Treatment Preferences Presented at: The annual meeting of the Association for Research and Vision in Ophthalmology (ARVO). Denver, CO, May 2015.",

author = "Soohoo, {Jeffrey R.} and Liliya Golas and Marando, {Catherine M.} and Seibold, {Leonard K.} and Pantcheva, {Mina B.} and Ramulu, {Pradeep Y.} and Kahook, {Malik Y.}",

note = "Funding Information: Supported by the Slater Family Endowment (M.Y.K.). The sponsor or funding organization had no role in the design or conduct of this research. Funding Information: Financial Disclosures: The authors made the following disclosures: M.Y.K.: Consultant – Alcon, Allergan, Aerie Pharmaceuticals, Forsight Vision 5, and Tempest Ocular; Other – Alcon, Allergan, Aerie Pharmaceuticals, Forsight Vision 5, Tempest Ocular; Grants – Alcon, Allergan, Clarvista Medical, New World Medical, AMO, Glaukos, Aerie Pharmaceuticals, outside the submitted work; Patent – Clarvista, Glaukos, AMO, Shapetech; Grant funding - NEI. ",

year = "2016",

month = jul,

day = "1",

doi = "10.1016/j.ophtha.2016.01.018",

language = "English (US)",

volume = "123",

pages = "1621--1622",

journal = "Ophthalmology",

issn = "0161-6420",

publisher = "Elsevier Inc.",

number = "7",

}

TY - JOUR

T1 - Glaucoma Patient Treatment Preferences Presented at

T2 - The annual meeting of the Association for Research and Vision in Ophthalmology (ARVO). Denver, CO, May 2015.

AU - Soohoo, Jeffrey R.

AU - Golas, Liliya

AU - Marando, Catherine M.

AU - Seibold, Leonard K.

AU - Pantcheva, Mina B.

AU - Ramulu, Pradeep Y.

AU - Kahook, Malik Y.

N1 - Funding Information: Supported by the Slater Family Endowment (M.Y.K.). The sponsor or funding organization had no role in the design or conduct of this research. Funding Information: Financial Disclosures: The authors made the following disclosures: M.Y.K.: Consultant – Alcon, Allergan, Aerie Pharmaceuticals, Forsight Vision 5, and Tempest Ocular; Other – Alcon, Allergan, Aerie Pharmaceuticals, Forsight Vision 5, Tempest Ocular; Grants – Alcon, Allergan, Clarvista Medical, New World Medical, AMO, Glaukos, Aerie Pharmaceuticals, outside the submitted work; Patent – Clarvista, Glaukos, AMO, Shapetech; Grant funding - NEI.

PY - 2016/7/1

Y1 - 2016/7/1

UR - http://www.scopus.com/inward/record.url?scp=84959282286&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959282286&partnerID=8YFLogxK

U2 - 10.1016/j.ophtha.2016.01.018

DO - 10.1016/j.ophtha.2016.01.018

M3 - Article

C2 - 26948306

AN - SCOPUS:84959282286

SN - 0161-6420

VL - 123

SP - 1621

EP - 1622

JO - Ophthalmology

JF - Ophthalmology

IS - 7

ER -

Glaucoma Patient Treatment Preferences Presented at: The annual meeting of the Association for Research and Vision in Ophthalmology (ARVO). Denver, CO, May 2015.

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this